Total Funding
84
18
Total FundingSeries B raised
Growth Score 84 in past quarter
4 pts
Heat Score 18 in past quarter
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
16131
SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound.
- Michael Davidson: Co-FounderPast Role: Corvidia, Chief Science Officer
- Kenneth Greenberg: Co-Founder and CEOPast Role: Oncorus, Co-Founder, Sr. Director of Scientific Strategy
About the Company
SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound. Its mission is to develop genetic medicines that treat the root cause of human disease. SonoThera is expanding the possibilities of disease treatment with ultrasound-guided nonviral gene therapy for diseases with suboptimal or non-existent treatments. It
aims to improve the lives and health of millions of people.